Browsing byAuthorQuinn, S

Jump to a point in the index:
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2021-01-27Correction to: Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partnersSchofield, P; Gough, K; Hyatt, A; White, A; Frydenberg, M; Chambers, S; Gordon, LG; Gardiner, R; Murphy, DG; Cavedon, L; Richards, N; Murphy, B; Quinn, S; Juraskova, I
2021-01-01June 2021 EditorialKennan, MA; Narayan, B; Luca, E; Quinn, S; McCallum, I
2019-01-01Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer painMcCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S
2016-02-01Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness - An Exploratory StudyFerreira, DH; Silva, JP; Quinn, S; Abernethy, AP; Johnson, MJ; Oxberry, SG; Currow, DC
2015-01-01Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?Currow, DC; Quinn, S; Ekstrom, M; Kaasa, S; Johnson, MJ; Somogyi, AA; Klepstad, P
2013-12-01Can the LANSS scale be used to classify pain in chronic cancer pain trials?Hardy, J; Quinn, S; Fazekas, B; Agar, M; Currow, D
2013-08-01The longitudinal pattern of response when morphine is used to treat chronic refractory dyspneaCurrow, DC; Quinn, S; Greene, A; Bull, J; Johnson, MJ; Abernethy, AP
2012-10-10Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painHardy, J; Quinn, S; Fazekas, B; Plummer, J; Eckermann, S; Agar, M; Spruyt, O; Rowett, D; Currow, DC
2004-01Why Bounce is BadEager, DM; Chapman, C; Cavanagh, M; Quinn, S; Boland, B; Buchann, P; Warn, A; Harris, W; Eager, D; Corkery, L; Bingham, M; Robbe, F; Mitchell, R; Barnes, S